Skip to main content

and
  1. No Access

    Article

    Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence

    Multiple sclerosis (MS) is a devastating chronic autoimmune demyelinating disease of the central nervous system (CNS), thought to affect more than 2.5 million people worldwide. Regulation of the sleep-wake cyc...

    Mahshid Yeganeh Salehpour, Adriano Mollica, Saeideh Momtaz in Clinical Drug Investigation (2019)